143 related articles for article (PubMed ID: 33635537)
21. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
Fleming AJ; Smith SP; Paul CM; Hall NC; Daly BT; Agrawal A; Schuller DE
Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315
[TBL] [Abstract][Full Text] [Related]
22. PET-Based Staging Is Cost-Effective in Early-Stage Follicular Lymphoma.
Lo AC; James LP; Prica A; Raymakers A; Peacock S; Qu M; Louie AV; Savage KJ; Sehn LH; Hodgson D; Yang JC; Eich HTT; Wirth A; Hunink MGM
J Nucl Med; 2022 Apr; 63(4):543-548. PubMed ID: 34413148
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of sentinel lymph node scintigraphy and intraoperative gamma probing with gold standard elective neck dissection in patients with N0 oral squamous cell cancers.
Sundaram PS; Subramanyam P
Nucl Med Commun; 2019 Nov; 40(11):1138-1147. PubMed ID: 31568193
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic accuracy of F-18 FDG PET or PET/CT for detection of lymph node metastasis in clinically node negative head and neck cancer patients; A systematic review and meta-analysis.
Kim SJ; Pak K; Kim K
Am J Otolaryngol; 2019; 40(2):297-305. PubMed ID: 30473166
[TBL] [Abstract][Full Text] [Related]
25. Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer.
Myers LL; Wax MK
J Otolaryngol; 1998 Dec; 27(6):342-7. PubMed ID: 9857320
[TBL] [Abstract][Full Text] [Related]
26. Relative value of ultrasound, computed tomography and positron emission tomography imaging in the clinically node-negative neck in oral cancer.
Chaukar D; Dandekar M; Kane S; Arya S; Purandare N; Rangarajan V; Deshmukh A; Pai P; Chaturvedi P; D'Cruz A
Asia Pac J Clin Oncol; 2016 Jun; 12(2):e332-8. PubMed ID: 25131685
[TBL] [Abstract][Full Text] [Related]
27. Economic analysis of FDG-PET-guided management of the neck after primary chemoradiotherapy for node-positive head and neck squamous cell carcinoma.
Pryor DI; Porceddu SV; Scuffham PA; Whitty JA; Thomas PA; Burmeister BH
Head Neck; 2013 Sep; 35(9):1287-94. PubMed ID: 22987817
[TBL] [Abstract][Full Text] [Related]
28. Modelling Study with an Interactive Model Assessing the Cost-effectiveness of
Scholte M; Barentsz JO; Sedelaar JPM; Gotthardt M; Grutters JPC; Rovers MM
Eur Urol Focus; 2020 Sep; 6(5):967-974. PubMed ID: 30826284
[TBL] [Abstract][Full Text] [Related]
29. Neck dissection can be avoided after sequential chemoradiotherapy and negative post-treatment positron emission tomography-computed tomography in N2 head and neck squamous cell carcinoma.
Loo SW; Geropantas K; Beadsmoore C; Montgomery PQ; Martin WM; Roques TW
Clin Oncol (R Coll Radiol); 2011 Oct; 23(8):512-7. PubMed ID: 21501953
[TBL] [Abstract][Full Text] [Related]
30. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.
Tan A; Adelstein DJ; Rybicki LA; Saxton JP; Esclamado RM; Wood BG; Lorenz RR; Strome M; Carroll MA
Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):435-40. PubMed ID: 17515501
[TBL] [Abstract][Full Text] [Related]
31. Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior?
Brouwer J; de Bree R; Comans EF; Castelijns JA; Hoekstra OS; Leemans CR
Eur Arch Otorhinolaryngol; 2004 Oct; 261(9):479-83. PubMed ID: 14685887
[TBL] [Abstract][Full Text] [Related]
32. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
[TBL] [Abstract][Full Text] [Related]
33. Clinical Utility of Pretreatment and 3-Month
Mayo Z; Seyedin SN; Mallak N; Mott SL; Menda Y; Graham M; Anderson C
Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):595-600. PubMed ID: 30808209
[TBL] [Abstract][Full Text] [Related]
34. The value of PET/CT to assess clinically negative necks.
Ozer E; Naiboğlu B; Meacham R; Ryoo C; Agrawal A; Schuller DE
Eur Arch Otorhinolaryngol; 2012 Nov; 269(11):2411-4. PubMed ID: 22249837
[TBL] [Abstract][Full Text] [Related]
35. Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation.
Cooper KL; Meng Y; Harnan S; Ward SE; Fitzgerald P; Papaioannou D; Wyld L; Ingram C; Wilkinson ID; Lorenz E
Health Technol Assess; 2011 Jan; 15(4):iii-iv, 1-134. PubMed ID: 21276372
[TBL] [Abstract][Full Text] [Related]
36. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.
Schöder H; Carlson DL; Kraus DH; Stambuk HE; Gönen M; Erdi YE; Yeung HW; Huvos AG; Shah JP; Larson SM; Wong RJ
J Nucl Med; 2006 May; 47(5):755-62. PubMed ID: 16644744
[TBL] [Abstract][Full Text] [Related]
37. Positron emission tomography-computed tomography surveillance for the node-positive neck after chemoradiotherapy.
Rabalais AG; Walvekar R; Nuss D; McWhorter A; Wood C; Fields R; Mercante DE; Pou AM
Laryngoscope; 2009 Jun; 119(6):1120-4. PubMed ID: 19358193
[TBL] [Abstract][Full Text] [Related]
38. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
[TBL] [Abstract][Full Text] [Related]
39. The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the N0 neck.
Hollenbeak CS; Lowe VJ; Stack BC
Cancer; 2001 Nov; 92(9):2341-8. PubMed ID: 11745289
[TBL] [Abstract][Full Text] [Related]
40. Improvement in the detection of locoregional recurrence in head and neck malignancies: F-18 fluorodeoxyglucose-positron emission tomography/computed tomography compared to high-resolution contrast-enhanced computed tomography and endoscopic examination.
Rangaswamy B; Fardanesh MR; Genden EM; Park EE; Fatterpekar G; Patel Z; Kim J; Som PM; Kostakoglu L
Laryngoscope; 2013 Nov; 123(11):2664-9. PubMed ID: 23553147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
